VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $10,225,000 | -17.2% | 713,550 | 0.0% | 2.16% | +21.8% |
Q2 2017 | $12,344,000 | +56.8% | 713,550 | 0.0% | 1.77% | +63.8% |
Q1 2017 | $7,870,000 | -24.0% | 713,550 | 0.0% | 1.08% | -43.0% |
Q4 2016 | $10,361,000 | -60.3% | 713,550 | -32.9% | 1.90% | -60.2% |
Q3 2016 | $26,098,000 | +21.9% | 1,063,057 | 0.0% | 4.76% | +63.6% |
Q2 2016 | $21,410,000 | -23.5% | 1,063,057 | -0.1% | 2.91% | +4.2% |
Q1 2016 | $27,974,000 | -59.4% | 1,063,657 | +56.9% | 2.79% | -41.9% |
Q4 2015 | $68,919,000 | +85.8% | 678,000 | +226.0% | 4.81% | +83.4% |
Q3 2015 | $37,103,000 | +14.9% | 208,000 | +43.1% | 2.62% | +43.5% |
Q2 2015 | $32,280,000 | +485.2% | 145,306 | +423.2% | 1.83% | +438.9% |
Q1 2015 | $5,516,000 | -63.4% | 27,770 | -73.6% | 0.34% | -57.7% |
Q4 2014 | $15,051,000 | +465.6% | 105,172 | +418.5% | 0.80% | +464.1% |
Q3 2014 | $2,661,000 | -92.9% | 20,284 | -93.1% | 0.14% | -93.9% |
Q2 2014 | $37,239,000 | +1100.5% | 295,267 | +1154.9% | 2.33% | +704.5% |
Q1 2014 | $3,102,000 | -35.9% | 23,529 | -42.9% | 0.29% | -18.8% |
Q4 2013 | $4,838,000 | – | 41,209 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |